MedPath

The effect of intranasal sodium cromoglycate on symptoms of suspected acute viral upper respiratory tract infection (URTI) in childre

Completed
Conditions
Primary care
Respiratory
Upper respiratory tract infection
Registration Number
ISRCTN21562211
Lead Sponsor
Medical Research Council (MRC) (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
300
Inclusion Criteria

Children aged from 6 months to 6 years with suspected acute viral URTI for less than 36 h

Exclusion Criteria

Children with: a history of having taken cromolyns or steroids within the previous week; carers who are incapable of giving informed consent or unable to keep symptom diaries; an established complication requiring immediate hospitalisation, or for whom the clinician plans to prescribe antibiotics at the first consultation.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
CARIFS Scale Score
Secondary Outcome Measures
NameTimeMethod
ot provided at time of registration
© Copyright 2025. All Rights Reserved by MedPath